🇺🇸 FDA
Patent

US 12214019

Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins

granted A61KA61K38/26A61K38/28

Quick answer

US patent 12214019 (Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins) held by Rani Therapeutics, LLC expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/26, A61K38/28, A61K9/2018, A61K9/2027